SCHEMBL23965786

SCHEMBL23965786

CCOC(=O)c1coc(-c2ccc(N3CC[C@@H](OC)C3)cc2)cc1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKD3 O94806 1/20 0.43
MAP4K4 O95819 1/20 0.43
PIM1 P11309 1/20 0.43
CLK2 P49760 1/20 0.43
MAP4K2 Q12851 1/20 0.43
CAMK2D Q13557 1/20 0.43
DYRK1A Q13627 1/20 0.43
PIM3 Q86V86 1/20 0.43
AURKB Q96GD4 1/20 0.43
PRKD2 Q9BZL6 1/20 0.43
CLK4 Q9HAZ1 1/20 0.43
STK17A Q9UEE5 1/20 0.43
MAP4K5 Q9Y4K4 1/20 0.43
CHRM1 P11229 1/20 0.39
TNKS O95271 1/20 0.37
USP8 P40818 1/20 0.36
USP30 Q70CQ3 5/20 0.36
SIRT2 Q8IXJ6 1/20 0.36
SIRT1 Q96EB6 1/20 0.36
ACACB O00763 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23965802 0.90 LIPG (0.40) PRKD3MAP4K4PIM1CLK2MAP4K2
SCHEMBL21668811 0.90 LIPG (0.40) PRKD3MAP4K4PIM1CLK2MAP4K2
SCHEMBL21669123 0.90 LIPG (0.40) PRKD3MAP4K4PIM1CLK2MAP4K2
SCHEMBL21668752 0.87 OPRK1 (0.38) PRKD3MAP4K4PIM1CLK2MAP4K2
SCHEMBL21638212 0.87 USP30 (0.40) CHRM1USP8USP30ACACB
SCHEMBL21638213 0.87 USP30 (0.40) CHRM1USP8USP30ACACB
SCHEMBL23965788 0.86 ACACB (0.40) ACACBMAPTLMNAL3MBTL1KDM4E
SCHEMBL21638142 0.84 ALDH1A1 (0.46) TNKSUSP8SIRT2SIRT1MAPT
SCHEMBL23839396 0.79 HTT (0.50) ACACBMAPTMEN1KMT2ALMNA
SCHEMBL23839398 0.79 HTT (0.50) ACACBMAPTMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11161830-B2 4-pyridone compound or salt thereof, and pharmaceutical composition and formulation including same FUJIFILM CORPORATION (JP) 2021-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11161830-B2 4-pyridone compound or salt thereof, and pharmaceutical composition and formulation including same HAVCR2, HBS1L, PHKB PRKD3 2738/4885MAP4K4 1009/4885PIM1 4360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.